ACR Meeting Abstracts
Abstract Number: 727 • ACR/ARHP Annual Meeting 2016
Mark Hwang1, Prabha Ranganathan2, MinJae Lee3, Seth Eisen1, Michael Ward4, Lianne S. Gensler5, Matthew A. Brown6, Johnathan Jia7, Amirali Tahanan3, Mohammad H. Rahbar3, Michael Weisman8 and John D. Reveille9, 1Internal Medicine-Rheumatology, Washington University in Saint Louis, School of Medicine, Saint Louis, MO, 2Washington University in Saint Louis, School of Medicine, Saint Louis, MO, 3Biostatistics/Epidemiology/Research Design (BERD) Core | Center for Clinical and Translational Sciences, University of Texas-McGovern Medical School, Houston, TX, 4NIH/NIAMS, Bethesda, MD, 5Medicine/Rheumatology, UCSF, San Francisco, CA, 6University of Queensland Diamantina Institute, Brisbane, Australia, 7University of Texas-McGovern Medical School, Houston, TX, 8Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, 9Rheumatology, University of Texas-McGovern Medical School, Houston, TX
Background/Purpose: NSAIDs are the first line pharmacologic therapy in ankylosing spondylitis (AS). Several NSAIDs are efficacious in AS without superiority demonstrated by any particular…